Literature DB >> 23716992

Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach.

Rong Cai1, Gang Ren, Deng-Bin Wang.   

Abstract

AIM: To review the clinicopathological characteristics of concurrent gastrointestinal stromal tumors (GISTs) and gastric adenocarcinoma.
METHODS: We retrospectively analyzed eight cases of synchronous adenocarcinoma and GIST in the stomach that had been surgically resected with curative intent between March 2003 and December 2008 in Xinhua hospital and Ruijin hospital. The adenocarcinoma was determined to be the primary tumor based on the histological features. The GIST cells were diffusely and strongly positive for CD34 and CD117.
RESULTS: The patients were six men and two women aged 47-80 years (average, 68.6 years). GIST was preoperatively detected in only one patient. The average sizes of the gastric adenocarcinomas and GISTs were 6.000 ± 2.6186 cm and 1.825 ± 1.4370 cm, respectively. All GISTs were very low- or low-risk lesions that were detected during evaluation, staging, operation or follow-up for gastric adenocarcinoma.
CONCLUSION: We hypothesized that the stomach was influenced by the same unknown carcinogen, resulting in a simultaneous proliferation of different cell lines (epithelial and stromal cell).

Entities:  

Keywords:  Gastrectomy; Gastric adenocarcinoma; Gastrointestinal stromal tumor; Synchronous occurrence

Mesh:

Substances:

Year:  2013        PMID: 23716992      PMCID: PMC3662952          DOI: 10.3748/wjg.v19.i20.3117

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

Review 1.  [A case of gastric cancer (IIb) on the submucosal tumor (leiomyoma) of the stomach].

Authors:  H Soejima; K Okada; S Matsuzaki; K Takasu; Y Tajima; Y Kajiwara; K Tanaka; N Kohara; T Matsumoto; T Eto
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1990-11

2.  Gastric adenocarcinoleiomyosarcoma: a light, electron microscopic and immunohistological study.

Authors:  S A Dundas; D N Slater; B E Wagner; P A Mills
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

Review 3.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

4.  Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.

Authors:  Regine Schneider-Stock; Carsten Boltze; Jerzy Lasota; Brigitte Peters; Chris L Corless; Petra Ruemmele; Luigi Terracciano; Matthias Pross; Luigi Insabato; Dolores Di Vizio; Igor Iesalnieks; Stefan Dirnhofer; Arndt Hartmann; Michel Heinrich; Markku Miettinen; Albert Roessner; Luigi Tornillo
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

5.  Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients.

Authors:  S Nakamura; K Aoyagi; S Iwanaga; T Yao; M Tsuneyoshi; M Fujishima
Journal:  Cancer       Date:  1997-03-15       Impact factor: 6.860

6.  Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate.

Authors:  A Cohen; S A Geller; I Horowitz; L S Toth; J L Werther
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

Review 7.  Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding.

Authors:  L Roncoroni; R Costi; G Canavese; V Violi; C Bordi
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

8.  Synchronous incidental gastrointestinal stromal and epithelial malignant tumors.

Authors:  Yan-Jun Liu; Zhou Yang; Lang-Song Hao; Lin Xia; Qian-Bin Jia; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

9.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

10.  Primary gastric adenosarcoma.

Authors:  B V Kallakury; H X Bui; A delRosario; J Wallace; O G Solis; J S Ross
Journal:  Arch Pathol Lab Med       Date:  1993-03       Impact factor: 5.534

View more
  6 in total

1.  Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors.

Authors:  Fang-Biao Zhang; Hong-Can Shi; Yu-Sheng Shu; Wei-Ping Shi; Shi-Chun Lu; Xiang-Yan Zhang; Shao-Song Tu
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

Review 2.  Plexiform fibromyxoma: Case report and literature review.

Authors:  Min Lin; Lu Song; Shuming Qin; Daosheng Li; Gang Hou; Xiaomei Li
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

3.  Synchronous occurrence of gastrointestinal stromal tumors and other digestive tract malignancies in the elderly.

Authors:  Chaoyong Shen; Haining Chen; Yuan Yin; Jiaju Chen; Luyin Han; Bo Zhang; Zhixin Chen; Jiaping Chen
Journal:  Oncotarget       Date:  2015-04-10

4.  Clinicopathological features and prognosis of coexistence of gastric gastrointestinal stromal tumor and gastric cancer.

Authors:  Zhen Liu; Shushang Liu; Gaozan Zheng; Jianjun Yang; Liu Hong; Li Sun; Daiming Fan; Hongwei Zhang; Fan Feng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors.

Authors:  Éva Kocsmár; Ildikó Kocsmár; Luca Szalai; Gábor Lendvai; Attila Szijártó; Zsuzsa Schaff; András Kiss; Ilona Kovalszky; Gergő Papp; Gábor Lotz
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

6.  Coexistence of Primary GEJ Adenocarcinoma and Pedunculated Gastric Gastrointestinal Stromal Tumor.

Authors:  Aroub Alkaaki; Basma Abdulhadi; Murad Aljiffry; Mohammed Nassif; Haneen Al-Maghrabi; Ashraf A Maghrabi
Journal:  Case Rep Surg       Date:  2018-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.